Citi raises Philip Morris stock target to $163, maintains buy
Citi analysts, led by Simon Hales, increased their price target on Philip Morris International Inc. (NYSE:PM) shares, ...
It's probably time you quit vaping. Here's how to do it
Vapes seemed cooler and generally less icky than cigarettes when they went mainstream a few years ago – vaping could be done, ...
Filter20h
FDA’s Authorization of Zyn Nicotine Pouches a Step in the Right Direction
The groundbreaking decision is a win for harm reduction, though it also highlights absurd contradictions in the FDA's overall ...
How Tucker Carlson’s Nicotine Pouch Became the Latest Front in the Culture War
It all started, Tucker Carlson told me, with a “boner joke.” In October 2023, the former Fox News host sat down with the internet comedian Theo Von in a Las Vegas hotel room to record an episode of ...
Philip Morris CEO: We're pleased with FDA approval of Zyn
Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.
Philip Morris' shares rise on optimistic 2025 outlook
Cigarette giant Philip Morris International on Thursday forecast better-than-expected profit growth for 2025, with ...
Philip Morris International: The Margin Of Safety Is Not As Wide Anymore
Philip Morris is a leading dividend business with strong smoke-free product growth, including IQOS and ZYN. Read why PM stock ...
Zyn, But With Weed: The Pouch Craze Hits The Cannabis Industry
Nicotine pouches have become a multibillion-dollar industry. Now Cannadips and other brands are putting their money where your mouth is.